PluroGen Therapeutics

company

About

PluroGen Therapeutics provides clinically advanced and advantaged burn, wound, and skin care products.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$1.70M
Industries
Health Care,Manufacturing,Medical,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

PluroGen's core technology platform was developed by researchers and physicians in University of Virginia's (UVA) Plastic Surgery Research Laboratory beginning in the 1970's. Their co-founder, George T. Rodeheaver, Ph.D., is one of the inventors of this technology and has supervised the formulation and production at UVA of one of their first products for use on burn and chronic wound patients at the UVA Health System for the past fifteen years.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$2.70M
PluroGen Therapeutics has raised a total of $2.70M in funding over 2 rounds. Their latest funding was raised on Jun 18, 2012 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 18, 2012 Angel $1M 1 Detail
Apr 13, 2007 Seed $1.70M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
PluroGen Therapeutics is funded by 2 investors. Keiretsu Forum and Virginia Active Angel Network are the most recent investors.
Investor Name Lead Investor Funding Round
Keiretsu Forum Angel
Virginia Active Angel Network Seed